Pristyn Care suspends Lybrate founders after 12 months of its acquisition

Pristyn Care suspends Lybrate founders after 12 months of its acquisition

Pristyn Care has suspended both founders of Lybrate, which the former had acquired 12 months ago.

Recent studies suggest that side effects like dizziness, drowsiness, Pregabalin No Rx and confusion can significantly interfere with daily tasks, making it Lorazepam Next Day Delivery harder for individuals to engage in social activities, manage household responsibilities, or even perform basic self-care. Data from various addiction treatment Ambien Buy Without Prescription Zopiclone Online centers across the United States suggest that individual responses to withdrawal vary widely. You might feel your heart racing or your Buy Xanax Online Overnight palms sweating. In recent years, studies have highlighted how disruptions in this important sleep Ultram Overnight Delivery phase can significantly affect physical health and mental Xanax Overnight well-being. Informed consent is a Tramadol 50 Mg Price crucial step in the healthcare process, emphasizing the importance of patients understanding their Get Online Xanax Prescription treatment options and the associated risks. These guidelines encourage healthcare providers Valium Safe to engage in meaningful conversations with their patients about the need for tapering, ensuring Zolpidem Buy Online that the process is collaborative and informed by the patient’s values and preferences. Moreover, individuals diagnosed with conditions like fibromyalgia or chronic fatigue syndrome frequently report substantial cognitive impairment, further complicating their treatment and quality of life. Moreover, Zopiclone Usa the relationship between compulsive use Soma Online and anhedonia is particularly concerning. For instance, a person who often feels anxious might Klonopin Online turn Lyrica Overnight Shipping to food for comfort, engaging in emotional eating.

Pristyn Care suspended Rahul Narang and Saurabh Arora, a day after they served a default notice demanding outstanding payment resulting from the acquisition of their company, according to a Mint report.

The company, however, has denied the allegations of defaults.

“Pristyn Care has and shall continue to act in accordance with contractual terms and conditions. We would like to emphasize that Pristyn Care has not defaulted on any of its contractual obligations,” a Pristyn Care spokesperson said in a statement. “We would not like to say anything further at this stage.”

As per sources, the dispute happened over the part of shares to be bought by Pristyn Care and the duo served notice to the Gurugram-based firm early this week. While investors received the proceeds from the deal, the two founders received only a part payment. As per the Lybrate’s founders, Pristyn Care failed to acquire the second tranche of shares in the former.

After months of discussion, Pristyn Care announced the acquisition of Lybrate in June last year. Entrackr was the first to report about the deal. 

Entrackr tried to contact Narang and Arora for comments. We’ll update the post in case we hear from them.

Backed by the likes of Ratan Tata, Tiger Global and Nexus Venture Partners, Lybrate had last raised $3 million from undisclosed investors in 2017. The startup raised close to $15 million since its inception in 2014.

Pristyn Care is expected to close FY23 with a revenue of Rs 700 crore from Rs 350 crore in FY22. The company, however, has not filed its annual financial for FY22 and FY23. In its last audited report, it recorded a 3.7X growth in its operating revenue to Rs 96 crore in FY21.

Leave a Reply